|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Boston, Massachusetts, US
|
|
Alpha-9 Theranostics is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
|
Alpha-9 Theranostics Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Alpha-9 Theranostics Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Alpha-9 Theranostics Inc. customer service number in your country click here to find.
David Hirsch is the CEO of Alpha-9 Theranostics Inc.. To contact David Hirsch email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.